Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer, today announced that John “Chip” A. Scarlett, M.D ...
This summer, Geron Corporation of Menlo Park, California, will begin treating ten patients who have suffered a complete thoracic-level spinal cord injury in a phase 1 multicenter trial.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback